| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/27/1997 | US5633012 Micro-encapsulated lactobacilli for medical applications |
| 05/27/1997 | US5632995 Method for stimulation of reproductive performance |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632893 Enhanced yield blood processing systems with angled interface control surface |
| 05/22/1997 | WO1997018317A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 05/22/1997 | WO1997018304A1 Methods for modulation of cholesterol transport |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018299A1 In vitro chondrogenic induction of human mesenchymal stem cells |
| 05/22/1997 | WO1997018298A1 Ex vivo culture of stem cells |
| 05/22/1997 | WO1997018297A1 Functional human hematopoietic cells |
| 05/22/1997 | WO1997017994A1 Treatment of diabetes with a glucokinase gene |
| 05/22/1997 | WO1997017981A1 Anti-viral isolates obtainable from leeches |
| 05/22/1997 | WO1997017980A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 05/22/1997 | WO1997012961A3 Growth of adult pancreatic islet cells with laminin 5 |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | CA2240192A1 Methods for screening compounds that modulate cholesterol transport |
| 05/22/1997 | CA2236332A1 Treatment of diabetes with a glucokinase gene |
| 05/22/1997 | CA2235394A1 Anti-viral isolates obtainable from leeches |
| 05/21/1997 | EP0774262A1 Pharmaceutical compositions comprising a neutralized virus and use thereof |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0773998A1 Novel vesicular acetylcholine carrier |
| 05/21/1997 | EP0773993A1 Genetically engineered swine cells |
| 05/21/1997 | EP0773951A1 Dinucleoside-5',5'-pyrophosphates |
| 05/21/1997 | EP0773795A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 05/21/1997 | EP0773785A2 Treatment of cancer using hsv mutant |
| 05/21/1997 | EP0773775A1 Freezing bags |
| 05/21/1997 | EP0650377A4 Implanting devices for release of neuroinhibitory compounds. |
| 05/21/1997 | CN1150388A Immunotherapeutic agent and its use |
| 05/21/1997 | CN1150041A Chinese patent medicine for curing gallstones and kidney stones |
| 05/21/1997 | CN1150040A Chinese medicine preparation |
| 05/21/1997 | CN1149975A Beautifying health candy containing pearl powder |
| 05/21/1997 | CN1034909C Composition for drug-taking stopping |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631162 Gene expression and dna sequences |
| 05/20/1997 | US5630410 Accelerated gas removal from divers' tissues utilizing gas metabolizing bacteria |
| 05/15/1997 | WO1997017434A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 05/15/1997 | WO1997017430A1 Reconstituted mineralized cartilage tissue |
| 05/15/1997 | WO1997017079A1 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
| 05/15/1997 | WO1997016977A1 Liquid colostrum for dairy products |
| 05/15/1997 | WO1997016967A1 Compositions and methods for promoting blood component survival |
| 05/15/1997 | DE19541735A1 Use of hydrothermal rock deposits e.g. calcite precursors |
| 05/15/1997 | CA2237200A1 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
| 05/15/1997 | CA2237180A1 Compositions and methods for promoting blood component survival |
| 05/15/1997 | CA2236807A1 Reconstituted mineralized cartilage tissue |
| 05/15/1997 | CA2235347A1 In vitro construction of sv40 viruses and pseudoviruses |
| 05/14/1997 | EP0773012A1 Means for atomizing mineral water |
| 05/14/1997 | EP0772690A1 Recombinant virus vectors |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |
| 05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 05/14/1997 | EP0772677A1 T cell activation |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772484A1 Fibrous web and process of preparing same |
| 05/14/1997 | EP0772456A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0650365B1 Biocidal composition containing mustard seed plant extract |
| 05/14/1997 | EP0603305B1 Use of a thymosin in the treatment of hepatitis c |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149478A Concentrated powder for colitis |
| 05/14/1997 | CN1149476A Ningshen medicinal composition for curing chronic retraction psychosis |
| 05/14/1997 | CN1149472A Nutritive preparation for computer operator and its production technology |
| 05/14/1997 | CN1149471A Nutrient for youngsters |
| 05/14/1997 | CN1149461A Processing and application method for peculiar smell microorgranism culture sample |
| 05/14/1997 | CN1149460A Chicken bile oral liquor |
| 05/14/1997 | CN1149422A High-nutrient biological synthetic functional health egg |
| 05/13/1997 | US5629194 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | CA2132045C Pharmaceutical composition for prophylaxis and treatment of premature ejaculation |
| 05/09/1997 | WO1997016557A1 TREATMENT OF TUMOURS BY ADOPTIVE TRANSFER OF CD44v-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 05/09/1997 | WO1997016536A1 Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof |
| 05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |
| 05/09/1997 | WO1997016534A1 Normal neural epithelial precursor cells |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016199A1 Methods for treatment of human immunodeficiency virus infection with a solvent extract derived from pseudomonas |
| 05/09/1997 | WO1997016198A1 Probiotically acting formulation |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016077A1 Probiotically acting formulations |
| 05/09/1997 | WO1997003186A3 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 05/09/1997 | CA2236345A1 Methods for treatment of human immunodeficiency virus infection with a solvent extract derived from pseudomonas |
| 05/09/1997 | CA2234230A1 Normal neural epithelial precursor cells |
| 05/09/1997 | CA2234102A1 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | CA2233250A1 Use of protein gax for treating cancer |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/07/1997 | EP0771869A1 Immunological tolerance inducing agent |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771356A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 05/07/1997 | EP0771355A1 A method for large scale plasmid purification |
| 05/07/1997 | EP0771326A1 Articles of manufacture for removing hiv-1 from a sample, and methods of using same |
| 05/07/1997 | EP0771324A1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 05/07/1997 | EP0771320A1 Polynucleotide decoys that ihnibit mhc-ii expression and uses thereof |
| 05/07/1997 | EP0771193A1 Activation of growth factors by matrix vesicles |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0599942B1 A method of making biocompatible capsules containing cells |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |